Scilex Holding Co SEC filings SCLX
Scilex Holding Co has 742 filings in SEC EDGAR's recent list, going back to Aug 19, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 5, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 24, 2026 |
| DEF 14A | Proxy statement | Nov 7, 2025 | Dec 11, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 28, 2025 | Dec 11, 2025 |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 4, 2025 |
| DEF 14A | Proxy statement | Feb 27, 2025 | Mar 19, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 14, 2025 | Mar 19, 2025 |
| DEF 14A | Proxy statement | Mar 12, 2024 | Apr 5, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEFA14A | Additional proxy material | Mar 27, 2023 | — |
| DEF 14A | Proxy statement | Mar 8, 2023 | Apr 6, 2023 |
| DEF 14A | Proxy statement | Jun 7, 2022 | Jun 30, 2022 |
| PRE 14A | Preliminary proxy statement | May 27, 2022 | May 27, 2022 |
Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SCLX (Nasdaq), SCLXW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1820190
- Former names
- Scilex Holding Company/DE (until Nov 30, 2022); Vickers Vantage Corp. I (until Nov 15, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.